316 related articles for article (PubMed ID: 25840417)
1. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
Malaguarnera R; Nicolosi ML; Sacco A; Morcavallo A; Vella V; Voci C; Spatuzza M; Xu SQ; Iozzo RV; Vigneri R; Morrione A; Belfiore A
Oncotarget; 2015 Jun; 6(18):16084-105. PubMed ID: 25840417
[TBL] [Abstract][Full Text] [Related]
2. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
3. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
[TBL] [Abstract][Full Text] [Related]
4. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src.
Lu KK; Trcka D; Bendeck MP
Cardiovasc Pathol; 2011; 20(2):71-6. PubMed ID: 20093046
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells.
Avino S; De Marco P; Cirillo F; Santolla MF; De Francesco EM; Perri MG; Rigiracciolo D; Dolce V; Belfiore A; Maggiolini M; Lappano R; Vivacqua A
Oncotarget; 2016 Aug; 7(33):52710-52728. PubMed ID: 27384677
[TBL] [Abstract][Full Text] [Related]
6. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.
Belfiore A; Malaguarnera R; Nicolosi ML; Lappano R; Ragusa M; Morrione A; Vella V
Cell Adh Migr; 2018; 12(4):305-314. PubMed ID: 29486622
[TBL] [Abstract][Full Text] [Related]
7. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
[TBL] [Abstract][Full Text] [Related]
8. The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair.
Hou G; Vogel W; Bendeck MP
J Clin Invest; 2001 Mar; 107(6):727-35. PubMed ID: 11254672
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1.
Hansen C; Greengard P; Nairn AC; Andersson T; Vogel WF
Exp Cell Res; 2006 Dec; 312(20):4011-8. PubMed ID: 17027969
[TBL] [Abstract][Full Text] [Related]
10. DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.
Vella V; Giuliano M; Nicolosi ML; Majorana MG; Marć MA; Muoio MG; Morrione A; Maggiolini M; Lappano R; De Francesco EM; Belfiore A
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206590
[TBL] [Abstract][Full Text] [Related]
11. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
[TBL] [Abstract][Full Text] [Related]
13. Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea.
Mohan RR; Mohan RR; Wilson SE
Exp Eye Res; 2001 Jan; 72(1):87-92. PubMed ID: 11133186
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives.
Vella V; Malaguarnera R
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513575
[TBL] [Abstract][Full Text] [Related]
15. Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.
Resnik JL; Reichart DB; Huey K; Webster NJ; Seely BL
Cancer Res; 1998 Mar; 58(6):1159-64. PubMed ID: 9515800
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
[TBL] [Abstract][Full Text] [Related]
17. Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis.
Kaulfuss S; Burfeind P; Gaedcke J; Scharf JG
Mol Cancer Ther; 2009 Apr; 8(4):821-33. PubMed ID: 19372555
[TBL] [Abstract][Full Text] [Related]
18. Collagen I regulates the self-renewal of mouse embryonic stem cells through α2β1 integrin- and DDR1-dependent Bmi-1.
Suh HN; Han HJ
J Cell Physiol; 2011 Dec; 226(12):3422-32. PubMed ID: 21344393
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase.
Sabbatini P; Rowand JL; Groy A; Korenchuk S; Liu Q; Atkins C; Dumble M; Yang J; Anderson K; Wilson BJ; Emmitte KA; Rabindran SK; Kumar R
Clin Cancer Res; 2009 May; 15(9):3058-67. PubMed ID: 19383820
[TBL] [Abstract][Full Text] [Related]
20. Collagen type I selectively activates ectodomain shedding of the discoidin domain receptor 1: involvement of Src tyrosine kinase.
Slack BE; Siniaia MS; Blusztajn JK
J Cell Biochem; 2006 Jun; 98(3):672-84. PubMed ID: 16440311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
